Peter Feinberg
Director · Immuneering Corp
- 2025
- Jun 11, 2026
- 5
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Peter Feinberg files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Thomas J. Schall - $101K in IMRX purchases and sales in the last 12 months
- Brett Matthew Hall - $36K in IMRX purchases and sales in the last 12 months
- Harold Eugene Brakewood - $25K in IMRX purchases and sales in the last 12 months
- Benjamin J. Zeskind - $11K in IMRX purchases and sales in the last 12 months
- Leah R. Neufeld - $11K in IMRX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Peter Feinberg?
Peter Feinberg is a corporate insider, tracked as Director of Immuneering Corp (IMRX). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Peter Feinberg last file a Form 4?
The most recent primary Form 4 on record is dated 11 June 2026, one of 5 filings going back to 2025.
Has Peter Feinberg been buying or selling stock?
Recorded transactions: 4 open-market purchases ($226K) and 0 open-market sales across all tracked filings.
